Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Blind Randomised Placebo Controlled Trial for Evaluation of Efficacy and Safety of Ingavirin® for Post-exposure Profilaxis During Rise in the Incidence of Influenza and Other Acute Respiratory Viral Infections in Adults

NCT03189537 is registered in ClinicalTrials.gov with Valenta Pharm JSC as lead sponsor.

NCT NCT03189537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03189537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Blind Randomised Placebo Controlled Trial for Evaluation of Efficacy and Safety of Ingavirin® for Post-exposure Profilaxis During Rise in the Incidence of Influenza and Other Acute Respiratory Viral Infections in Adults
Lead sponsor
Valenta Pharm JSC
Phase
Phase 3
Overall status
Completed
Start date
October 3, 2010
Completion date
October 10, 2011
Enrollment
400 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory infection, common cold, flu, influenza, human, viral infection